Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation
about
Male fertility defects in mice lacking the serine protease inhibitor protease nexin-1Mobile DHHC palmitoylating enzyme mediates activity-sensitive synaptic targeting of PSD-95Diverse impact of acute and long-term extracellular proteolytic activity on plasticity of neuronal excitabilityThrombin regulation of synaptic transmission and plasticity: implications for health and diseaseNeural and cellular mechanisms of fear and extinction memory formationNeuropathology in mice expressing mouse alpha-synucleinEarly lethality and neuronal proteinopathy in mice expressing cytoplasm-targeted FUS that lacks the RNA recognition motif.Early-onset and robust amyloid pathology in a new homozygous mouse model of Alzheimer's diseaseMolecular constituents of neuronal AMPA receptorsSerine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behaviorGlutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegenerationDisruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy.Increased tau phosphorylation on mitogen-activated protein kinase consensus sites and cognitive decline in transgenic models for Alzheimer's disease and FTDP-17: evidence for distinct molecular processes underlying tau abnormalitiesCo-expression of truncated and full-length tau induces severe neurotoxicityNewly generated cells are increased in hippocampus of adult mice lacking a serine protease inhibitor.Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase.Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis.Neurofascin 140 is an embryonic neuronal neurofascin isoform that promotes the assembly of the node of RanvierThe temporal expression pattern of alpha-synuclein modulates olfactory neurogenesis in transgenic mice.Conditional expression of human β-hexosaminidase in the neurons of Sandhoff disease rescues mice from neurodegeneration but not neuroinflammation.Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamineThe contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemiaTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.Alteration of synaptic plasticity by neonatal seizures in rat somatosensory cortex.Endogenous protease nexin-1 protects against cerebral ischemia.Treating seizures and epilepsy with anticoagulants?Theta-burst LTPAssembly of CNS Nodes of Ranvier in Myelinated Nerves Is Promoted by the Axon Cytoskeleton.The neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) alters hippocampal excitatory synaptic transmission by modulation of the GABAergic systemA disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse modelIn vitro and in vivo antiangiogenic properties of the serpin protease nexin-1A critical role for Neurofascin in regulating action potential initiation through maintenance of the axon initial segment.Oligomer-prone E57K-mutant alpha-synuclein exacerbates integration deficit of adult hippocampal newborn neurons in transgenic mice.Serpine2 deficiency results in lung lymphocyte accumulation and bronchus-associated lymphoid tissue formation.Structural basis of epilepsy-related ligand-receptor complex LGI1-ADAM22.Pathophysiology of Trans-Synaptic Adhesion Molecules: Implications for EpilepsyHematopoietic protease nexin-1 protects against lung injury by preventing thrombin signaling in mice
P2860
Q24634146-ABE59A9A-874F-4AC0-87B3-6D62A5874750Q24647301-A41ACF8D-19B3-41AD-AD1F-18B76A172B5FQ26796239-B12FEA6E-6090-4229-8072-FA147D7C14F0Q26827343-E8C832A8-BA31-42EA-A662-C1A81212AE5DQ26853333-964664AA-59D9-4093-A325-0B6BAB7F9349Q27320029-5E265036-FD91-4803-B37F-85304E6F43D1Q27334411-72F152B9-3104-4248-9CD5-A07400B00110Q27335191-C0898B2C-625B-4D29-9DC9-2108B7A3AF91Q28593335-7AB21B87-E1FE-415E-9AD7-73C0900DE720Q28741929-0018A930-07EB-4FCA-BFD5-F0392B59E307Q30446186-2F620DFD-2752-45FA-85E8-ECA3DD4FC47EQ30482626-4CF853C8-4528-46E1-809E-DC8EF6F9B15FQ30500257-D65792C4-9B61-43D7-AE54-AAEB151059A3Q30829185-16689E9D-07E5-4D91-8401-295A132E5A8AQ33596951-9FC0ADE9-A690-42EE-9AE5-1A5347CFA899Q33744544-3CF56D6D-1121-4225-A280-A41D29640DACQ33845781-44B10C0C-FFE7-43C5-AAD9-2B1315817478Q35044841-47DC708A-5283-4D12-A31C-E66B4CA3AAF9Q35593656-68D74BE9-7321-4F37-BEE6-7C1308E8C3EFQ36281480-3757D357-C0B2-4056-AD12-AD140AD65249Q36323501-41B13217-87FC-4E6F-9EAD-DC90240C6929Q36690082-91625D5C-70B8-44C9-B3BC-F670480704CBQ36724967-9CAF0E44-6F46-45F5-B3CF-5694383391CDQ37136675-67C2A28D-4344-408C-8E55-DACB4C548D05Q37139215-24932914-B879-44EA-BA87-9B38DCE8ED9DQ38087217-102454A1-9008-41D8-8C59-36E62B591A02Q38276054-F0ED795D-55F1-4BD7-89D3-7CE4C2C283E4Q38893955-06452C56-8640-4AAE-9A7A-647BA0384EB2Q40614367-4D3E4167-ECE0-4ED8-8798-878086106087Q40841974-5727F0A9-15CA-47F8-876F-9A2188728B01Q41835454-2C8173CA-D0E0-485D-9CE7-64E537AB49BBQ42687432-4CA432F4-9519-4CD2-9AAC-654E9BB80731Q46264316-D3BE033B-3E18-4C15-965A-526A7ED2A871Q48058728-B7E09DCB-ABC9-4BA0-9DF9-D85D97AC6AD5Q52316668-9DBB1EF4-DB30-496D-931A-611B0F2CA3BAQ57299992-2D56DB57-6447-4B0D-A1FC-3C68B23C6542Q58698399-562C18DE-7348-412C-9684-6C9143784168
P2860
Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation
description
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1997
@ast
im Juni 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1997/06/15)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/06/15)
@nl
наукова стаття, опублікована в червні 1997
@uk
مقالة علمية (نشرت في 15-6-1997)
@ar
name
Endogenous serine protease inh ...... ocampal long-term potentiation
@ast
Endogenous serine protease inh ...... ocampal long-term potentiation
@en
Endogenous serine protease inh ...... ocampal long-term potentiation
@nl
type
label
Endogenous serine protease inh ...... ocampal long-term potentiation
@ast
Endogenous serine protease inh ...... ocampal long-term potentiation
@en
Endogenous serine protease inh ...... ocampal long-term potentiation
@nl
prefLabel
Endogenous serine protease inh ...... ocampal long-term potentiation
@ast
Endogenous serine protease inh ...... ocampal long-term potentiation
@en
Endogenous serine protease inh ...... ocampal long-term potentiation
@nl
P2093
P1476
Endogenous serine protease inh ...... ocampal long-term potentiation
@en
P2093
F M Botteri
H Van der Putten
I M Mansuy
J P Laurent
P304
P356
10.1523/JNEUROSCI.17-12-04688.1997
P407
P577
1997-06-01T00:00:00Z